Clinical evaluation of a new sugar coated potassium chloride supplement

Hutchison, JC

HERO ID

4947804

Reference Type

Journal Article

Year

1974

Language

English

HERO ID 4947804
In Press No
Year 1974
Title Clinical evaluation of a new sugar coated potassium chloride supplement
Authors Hutchison, JC
Journal Journal of Clinical Pharmacology
Volume 14
Issue 11 (Nov-Dec)
Page Numbers 624-629
Abstract IPA COPYRIGHT: ASHP Potassium chloride, as a sugar coated tablet embedded in a wax matrix (Slow-K) and potassium gluconate solution (Kaon), were compared in 20 outpatients suffering from hypertension and receiving potassium wasting diuretics, capable of producing hypokalemia. The patients were randomly divided into 2 groups of 10 each. One group received the solution for 4 weeks (40 meq potassium/day) and was then switched to the tablet (48 meq/day) for another 4 weeks. The second group began treatment with the tablet, crossing over to the solution after 4 weeks. The patients completed a self rating questionnaire on preference and GI side effects after each 4 week period. Both medications appeared equally effective in maintaining serum levels of potassium and chloride. GI side effects were not severe with either preparation. No gross or occult blood was detected in the stools for any patient. Patient preferences favored the tablet. Ninety-five per cent of the subjects found the tablets more acceptable than the liquid, and 90% found them more convenient. Based upon these findings, the tablet appears to possess decided clinical advantage over a solution with respect to patient compliance and acceptance.
Doi 10.1002/j.1552-4604.1974.tb01383.x
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English